We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – News and Features

News

New Leadership for the Organization Leading the Funding of Mesothelioma Research

The Mesothelioma Applied Research Foundation, the leading organization funding mesothelioma research and providing patient services, announced the election of new Co-Chairs of its Board of Directors.
News

Healthcare at Home Ltd Acquires Health Informatics Specialists Sciensus Ltd

Healthcare at Home Ltd, a provider of home-based healthcare and specialty pharmacy services, is today pleased to announce that it has acquired Sciensus Ltd, a provider of health informatics for clients across the NHS and the pharmaceutical industry.
News

Human T Cell and Antibody-Mediated Responses to the Mycobacterium tuberculosis Recombinant 85A, 85B, and ESAT-6 Antigens

An article published in Clinical and Developmental Immunology details how researchers have investigated humoral and cellular immune responses to M. tuberculosis-specific Ag85A, Ag85B, and ESAT-6 antigens in Brazilian patients with pulmonary or extrapulmonary tuberculosis, patients undergoing chemotherapy and noninfected healthy individuals.
News

NewLink Genetics to Present Phase 2 Data of its HyperAcute® Pancreas Immunotherapy

The data will be presented during a poster session at the ASCO 2011 Gastrointestinal Cancers Symposium in San Francisco, California.
News

Everist Genomics Announces External Validation of OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients

New Data Presented at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium Demonstrate Potential for Optimizing Clinical Management of Early Stage Colon and Rectal Cancers.
News

Peregrine Announces Initiation of Investigator-sponsored Trial in HER2-Negative Metastatic Breast Cancer

The Phase I trial will treat patients with Peregrine's monoclonal antibody bavituximab in combination with the chemotherapy agent paclitaxel.
News

4SC Announces First Patient Dosed in Phase I/II SHORE Study with Resminostat

The first patient dosed in the study with resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
News

MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients with HER2-expressing Solid Tumors

MGAH22 is an Fc-optimized monoclonal antibody developed by MacroGenics to reduce tumor growth significantly in a broad panel of HER2-expressing tumors.
News

Gene Variants Predict Treatment Success for Alcoholim Medication

NIH-supported study demonstrates the promise of personalized medicine.
News

Oncolytics Biotech® Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study

Patients will be randomized to receive either carboplatin, paclitaxel plus REOLYSIN or carboplatin and paclitaxel alone.
Advertisement